COX-2 inhibitors: lower risk of pancreatitis than other NSAIDs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1552, 2006-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective COX-2 inhibitors may pose a greater risk of hyperkalaemia than nonselective NSAIDs

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Selective COX-2 inhibitors vs NSAIDs discussed

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention

By Ballinger A. Smith G.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 31-40

Informa Healthcare

Access to resources Recommend Favorite

Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors

By Latimer Nicholas

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 225-237

Adis International

Access to resources Recommend Favorite